Clinical Trial Update: Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, adverse events, changes in disease activity, and pharmacokinetics of intravenously infused ABBV-291 in adults with Non-Hodgkin …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• ABBV-291

Snippet

Sponsor: AbbVie | Conditions: Non-Hodgkin's Lymphoma | Phase 1 | Status: RECRUITING